The 13th Fanconi anemia gene identified: FANCI - Importance of the 'Fanconi anemia pathway' for cellular oncology

Cellular Oncology

Volumn 29, Issue 3, 2007, Pages 181-182

  Meijer, Gerrit A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; HELICASE; MELPHALAN; MITOMYCIN C;

CHROMOSOMAL INSTABILITY; CHROMOSOME BREAKAGE; CROSS LINKING; EDITORIAL; FANCONI ANEMIA; FANCONI ANEMIA GENE; GENE; GENE IDENTIFICATION; GENE MUTATION; HETEROZYGOTE; HUMAN; MISMATCH REPAIR; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; NEOPLASMS;

EID: 34249811785     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. G. Meijer, Chromosomes and cancer, Boveri revisited, Cell. Oncol. 27 (2005), 273-275.
2. P. Duesberg, R. Li, A. Fabarius and R. Hehlmann, The chromosomal basis of cancer, Cell. Oncol. 27 (2005), 293-318.
3. W. Giaretti, Vanishing conflicts on cancer theories, Cell. Oncol. 28 (2006), 1-2.
4. M. Grade, H. Becker, T. Liersch, T. Ried and B. Ghadimi, Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact, Cell. Oncol. 28 (2006), 71-84.
5. T. Buffart, J. Coffa, M. Hermsen, B. Carvalho, J. van der Sijp, B. Ylstra, G. Pals, J. Schouten and G. Meijer, DNA copy number changes at 8q11-24 in metastasized colorectal cancer, Cell. Oncol. 27 (2005), 57-65.
6. M. Levitus, H. Joenje and J. de Winter, The Fanconi anemia pathway of genomic maintenance, Cell. Oncol. 28 (2006), 3-29.
7. C. Jacquemont and T. Taniguchi, Disruption of the Fanconi anemia pathway in human cancer, Cancer Biol. Ther. 5 (2006), 1637-1639.
8. A. Lyakhovich and J. Surralles, Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer, Cancer Lett. 232 (2006), 99-106.
9. T. Taniguchi, M. Tischkowitz, N. Ameziane, S.V. Hodgson, C.G. Mathew, H. Joenje, S.C. Mok and A.D. D'Andrea, Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors, Nat. Med. 9 (2003), 568-574.
10. M. Tischkowitz, N. Ameziane, Q. Waisfisz, J.P. de Winter, R. Harris, T. Taniguchi, A. D'Andrea, S.V. Hodgson, C.G. Mathew and H. Joenje, Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukemia, Br. J. Haematol. 123 (2003), 469-471.
11. D. Chrinomas, T. Taniguchi, M. de la Vega, A.P. Vaidya, M. Vasserman, A.R. Hartman, R. Kennedy, R. Foster, J. Mahoney, M.V. Seiden and A.D. D'Andrea, Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway, Mol. Cancer Ther. 5 (2006), 952-961.
12. H.E. Bryant, N. Schultz, H.D. Thomas, K.M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N.J. Curtin and T. Helleday, Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase, Nature 434 (2005), 913-977.
13. H. Farmer, N. McCabe, C.J. Lord, A.N. Tutt, D.A. Johnson, T.B. Richardson, M. Santarose, K.J. Dillon, I. Hickson, C. Knights, N.M. Martin, S.P. Jackson, G.C. Smith and A. Ashworth, Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy, Nature 434 (2005), 917-921.